nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—CYP1A1—lung cancer	0.164	0.653	CbGaD
Haloperidol—ABCB1—lung cancer	0.087	0.347	CbGaD
Haloperidol—CBR1—Doxorubicin—lung cancer	0.0678	0.141	CbGbCtD
Haloperidol—UGT1A9—Irinotecan—lung cancer	0.0313	0.0651	CbGbCtD
Haloperidol—CYP1A1—Gefitinib—lung cancer	0.0243	0.0506	CbGbCtD
Haloperidol—CYP3A5—Gefitinib—lung cancer	0.0146	0.0304	CbGbCtD
Haloperidol—CYP1A1—Erlotinib—lung cancer	0.0144	0.0299	CbGbCtD
Haloperidol—CYP3A5—Teniposide—lung cancer	0.0142	0.0295	CbGbCtD
Haloperidol—CYP2C19—Gefitinib—lung cancer	0.0118	0.0245	CbGbCtD
Haloperidol—CYP2C19—Teniposide—lung cancer	0.0114	0.0238	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.0105	0.0219	CbGbCtD
Haloperidol—CYP3A7—Paclitaxel—lung cancer	0.0105	0.0219	CbGbCtD
Haloperidol—CYP3A7—Irinotecan—lung cancer	0.0104	0.0216	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.0104	0.0216	CbGbCtD
Haloperidol—ABCB1—Topotecan—lung cancer	0.0104	0.0216	CbGbCtD
Haloperidol—CYP2C9—Gefitinib—lung cancer	0.00979	0.0204	CbGbCtD
Haloperidol—ABCB1—Gefitinib—lung cancer	0.0095	0.0198	CbGbCtD
Haloperidol—CYP2C9—Teniposide—lung cancer	0.00949	0.0198	CbGbCtD
Haloperidol—CYP2D6—Gefitinib—lung cancer	0.00895	0.0186	CbGbCtD
Haloperidol—CYP3A5—Crizotinib—lung cancer	0.00895	0.0186	CbGbCtD
Haloperidol—CYP3A5—Erlotinib—lung cancer	0.00863	0.018	CbGbCtD
Haloperidol—CYP3A5—Paclitaxel—lung cancer	0.0079	0.0165	CbGbCtD
Haloperidol—CYP3A5—Irinotecan—lung cancer	0.00779	0.0162	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.00761	0.0159	CbGbCtD
Haloperidol—CYP3A7—Docetaxel—lung cancer	0.00761	0.0159	CbGbCtD
Haloperidol—ABCB1—Vinorelbine—lung cancer	0.00732	0.0152	CbGbCtD
Haloperidol—CYP2D6—Vinorelbine—lung cancer	0.00689	0.0144	CbGbCtD
Haloperidol—CYP1A2—Erlotinib—lung cancer	0.00642	0.0134	CbGbCtD
Haloperidol—CYP3A5—Etoposide—lung cancer	0.00624	0.013	CbGbCtD
Haloperidol—CYP3A4—Topotecan—lung cancer	0.00622	0.013	CbGbCtD
Haloperidol—ABCB1—Crizotinib—lung cancer	0.00582	0.0121	CbGbCtD
Haloperidol—CYP3A5—Docetaxel—lung cancer	0.00571	0.0119	CbGbCtD
Haloperidol—CYP3A4—Gefitinib—lung cancer	0.00569	0.0119	CbGbCtD
Haloperidol—ABCB1—Gemcitabine—lung cancer	0.00569	0.0119	CbGbCtD
Haloperidol—ABCB1—Erlotinib—lung cancer	0.00562	0.0117	CbGbCtD
Haloperidol—CYP3A4—Teniposide—lung cancer	0.00552	0.0115	CbGbCtD
Haloperidol—CYP2C9—Paclitaxel—lung cancer	0.0053	0.011	CbGbCtD
Haloperidol—CYP2D6—Erlotinib—lung cancer	0.00529	0.011	CbGbCtD
Haloperidol—HTR2A—phrenic nerve—lung cancer	0.00527	0.17	CbGeAlD
Haloperidol—ABCB1—Paclitaxel—lung cancer	0.00514	0.0107	CbGbCtD
Haloperidol—ABCB1—Irinotecan—lung cancer	0.00507	0.0106	CbGbCtD
Haloperidol—CYP1A2—Etoposide—lung cancer	0.00465	0.00968	CbGbCtD
Haloperidol—ABCB1—Vinblastine—lung cancer	0.00451	0.00939	CbGbCtD
Haloperidol—CYP3A4—Vinorelbine—lung cancer	0.00438	0.00913	CbGbCtD
Haloperidol—CYP2C9—Cisplatin—lung cancer	0.00426	0.00887	CbGbCtD
Haloperidol—CYP2D6—Vinblastine—lung cancer	0.00425	0.00885	CbGbCtD
Haloperidol—ABCB1—Cisplatin—lung cancer	0.00413	0.00861	CbGbCtD
Haloperidol—ABCB1—Etoposide—lung cancer	0.00406	0.00846	CbGbCtD
Haloperidol—ABCB1—Docetaxel—lung cancer	0.00372	0.00774	CbGbCtD
Haloperidol—CYP3A4—Crizotinib—lung cancer	0.00349	0.00727	CbGbCtD
Haloperidol—CYP3A4—Erlotinib—lung cancer	0.00337	0.00701	CbGbCtD
Haloperidol—CYP3A4—Paclitaxel—lung cancer	0.00308	0.00642	CbGbCtD
Haloperidol—CYP3A4—Irinotecan—lung cancer	0.00304	0.00633	CbGbCtD
Haloperidol—ABCB1—Doxorubicin—lung cancer	0.00277	0.00577	CbGbCtD
Haloperidol—CYP3A4—Vinblastine—lung cancer	0.0027	0.00563	CbGbCtD
Haloperidol—ABCB1—Methotrexate—lung cancer	0.00268	0.00559	CbGbCtD
Haloperidol—CYP2D6—Doxorubicin—lung cancer	0.00261	0.00544	CbGbCtD
Haloperidol—CYP3A4—Etoposide—lung cancer	0.00243	0.00507	CbGbCtD
Haloperidol—CYP3A4—Docetaxel—lung cancer	0.00223	0.00464	CbGbCtD
Haloperidol—HTR2A—pulmonary artery—lung cancer	0.00191	0.0616	CbGeAlD
Haloperidol—CYP3A4—Doxorubicin—lung cancer	0.00166	0.00346	CbGbCtD
Haloperidol—CBR1—mammary gland—lung cancer	0.00153	0.0493	CbGeAlD
Haloperidol—H1F0—mammary gland—lung cancer	0.00125	0.0404	CbGeAlD
Haloperidol—CBR1—Vincristine—Vinorelbine—lung cancer	0.00103	0.411	CbGdCrCtD
Haloperidol—CBR1—respiratory system—lung cancer	0.00102	0.0329	CbGeAlD
Haloperidol—SIGMAR1—mammary gland—lung cancer	0.000906	0.0292	CbGeAlD
Haloperidol—CBR1—bronchus—lung cancer	0.00084	0.0271	CbGeAlD
Haloperidol—H1F0—respiratory system—lung cancer	0.000836	0.0269	CbGeAlD
Haloperidol—CBR1—Vincristine—Vinblastine—lung cancer	0.000825	0.329	CbGdCrCtD
Haloperidol—CBR1—trachea—lung cancer	0.000754	0.0243	CbGeAlD
Haloperidol—CBR1—cardiac atrium—lung cancer	0.000708	0.0228	CbGeAlD
Haloperidol—H1F0—bronchus—lung cancer	0.000688	0.0222	CbGeAlD
Haloperidol—Loperamide—POMC—lung cancer	0.000632	0.894	CrCbGaD
Haloperidol—H1F0—trachea—lung cancer	0.000618	0.0199	CbGeAlD
Haloperidol—CBR1—bone marrow—lung cancer	0.000598	0.0193	CbGeAlD
Haloperidol—CYP2C9—mammary gland—lung cancer	0.000586	0.0189	CbGeAlD
Haloperidol—H1F0—cardiac atrium—lung cancer	0.00058	0.0187	CbGeAlD
Haloperidol—CBR1—lung—lung cancer	0.000542	0.0175	CbGeAlD
Haloperidol—SIGMAR1—bronchus—lung cancer	0.000497	0.016	CbGeAlD
Haloperidol—H1F0—bone marrow—lung cancer	0.00049	0.0158	CbGeAlD
Haloperidol—DRD2—respiratory system—lung cancer	0.000488	0.0157	CbGeAlD
Haloperidol—SIGMAR1—trachea—lung cancer	0.000446	0.0144	CbGeAlD
Haloperidol—H1F0—lung—lung cancer	0.000444	0.0143	CbGeAlD
Haloperidol—SIGMAR1—cardiac atrium—lung cancer	0.000419	0.0135	CbGeAlD
Haloperidol—CYP1A2—respiratory system—lung cancer	0.000411	0.0133	CbGeAlD
Haloperidol—CYP1A1—respiratory system—lung cancer	0.000406	0.0131	CbGeAlD
Haloperidol—CYP3A5—respiratory system—lung cancer	0.000397	0.0128	CbGeAlD
Haloperidol—CBR1—Azacitidine—Gemcitabine—lung cancer	0.000389	0.155	CbGdCrCtD
Haloperidol—HRH1—respiratory system—lung cancer	0.000385	0.0124	CbGeAlD
Haloperidol—CBR1—lymph node—lung cancer	0.000371	0.0119	CbGeAlD
Haloperidol—SIGMAR1—bone marrow—lung cancer	0.000354	0.0114	CbGeAlD
Haloperidol—CYP1A1—epithelium—lung cancer	0.000339	0.0109	CbGeAlD
Haloperidol—CYP1A1—bronchus—lung cancer	0.000334	0.0108	CbGeAlD
Haloperidol—KCNH2—cardiac atrium—lung cancer	0.000334	0.0108	CbGeAlD
Haloperidol—HRH1—epithelium—lung cancer	0.000322	0.0104	CbGeAlD
Haloperidol—HTR2A—respiratory system—lung cancer	0.000322	0.0104	CbGeAlD
Haloperidol—SIGMAR1—lung—lung cancer	0.000321	0.0103	CbGeAlD
Haloperidol—HTR2B—lung—lung cancer	0.00032	0.0103	CbGeAlD
Haloperidol—H1F0—lymph node—lung cancer	0.000304	0.00978	CbGeAlD
Haloperidol—CYP1A1—trachea—lung cancer	0.0003	0.00967	CbGeAlD
Haloperidol—HRH1—trachea—lung cancer	0.000285	0.00917	CbGeAlD
Haloperidol—CYP1A1—cardiac atrium—lung cancer	0.000282	0.00908	CbGeAlD
Haloperidol—KCNH2—bone marrow—lung cancer	0.000282	0.00908	CbGeAlD
Haloperidol—HTR2A—epithelium—lung cancer	0.000269	0.00866	CbGeAlD
Haloperidol—EBP—Azacitidine—Gemcitabine—lung cancer	0.000265	0.105	CbGdCrCtD
Haloperidol—DRD2—lung—lung cancer	0.000259	0.00835	CbGeAlD
Haloperidol—HTR2A—trachea—lung cancer	0.000238	0.00766	CbGeAlD
Haloperidol—SIGMAR1—lymph node—lung cancer	0.000219	0.00707	CbGeAlD
Haloperidol—HTR2B—lymph node—lung cancer	0.000219	0.00705	CbGeAlD
Haloperidol—CYP1A2—lung—lung cancer	0.000218	0.00704	CbGeAlD
Haloperidol—CYP1A1—lung—lung cancer	0.000215	0.00694	CbGeAlD
Haloperidol—ABCB1—respiratory system—lung cancer	0.000211	0.00679	CbGeAlD
Haloperidol—CYP3A5—lung—lung cancer	0.000211	0.00679	CbGeAlD
Haloperidol—HRH1—lung—lung cancer	0.000205	0.00659	CbGeAlD
Haloperidol—ABCB1—epithelium—lung cancer	0.000176	0.00568	CbGeAlD
Haloperidol—KCNH2—lymph node—lung cancer	0.000175	0.00562	CbGeAlD
Haloperidol—HTR2A—lung—lung cancer	0.000171	0.0055	CbGeAlD
Haloperidol—ABCB1—trachea—lung cancer	0.000156	0.00502	CbGeAlD
Haloperidol—CYP1A1—lymph node—lung cancer	0.000147	0.00475	CbGeAlD
Haloperidol—HRH1—lymph node—lung cancer	0.00014	0.00451	CbGeAlD
Haloperidol—ABCB1—bone marrow—lung cancer	0.000124	0.00398	CbGeAlD
Haloperidol—ABCB1—lung—lung cancer	0.000112	0.00361	CbGeAlD
Haloperidol—Nausea—Topotecan—lung cancer	9.44e-05	0.000754	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Gemcitabine—lung cancer	9.43e-05	0.000753	CcSEcCtD
Haloperidol—Confusional state—Etoposide—lung cancer	9.4e-05	0.000751	CcSEcCtD
Haloperidol—Cardiac arrest—Doxorubicin—lung cancer	9.36e-05	0.000747	CcSEcCtD
Haloperidol—Constipation—Gemcitabine—lung cancer	9.34e-05	0.000746	CcSEcCtD
Haloperidol—Nausea—Erlotinib—lung cancer	9.34e-05	0.000746	CcSEcCtD
Haloperidol—Pancytopenia—Methotrexate—lung cancer	9.33e-05	0.000745	CcSEcCtD
Haloperidol—Dry mouth—Paclitaxel—lung cancer	9.33e-05	0.000745	CcSEcCtD
Haloperidol—Anaphylactic shock—Etoposide—lung cancer	9.33e-05	0.000745	CcSEcCtD
Haloperidol—Diarrhoea—Vinorelbine—lung cancer	9.3e-05	0.000743	CcSEcCtD
Haloperidol—Feeling abnormal—Irinotecan—lung cancer	9.24e-05	0.000738	CcSEcCtD
Haloperidol—Confusional state—Paclitaxel—lung cancer	9.22e-05	0.000736	CcSEcCtD
Haloperidol—Neutropenia—Methotrexate—lung cancer	9.19e-05	0.000734	CcSEcCtD
Haloperidol—Oedema—Paclitaxel—lung cancer	9.14e-05	0.00073	CcSEcCtD
Haloperidol—Anaphylactic shock—Paclitaxel—lung cancer	9.14e-05	0.00073	CcSEcCtD
Haloperidol—Thrombocytopenia—Etoposide—lung cancer	9.13e-05	0.000729	CcSEcCtD
Haloperidol—Muscle spasms—Docetaxel—lung cancer	9.13e-05	0.000729	CcSEcCtD
Haloperidol—Tachycardia—Etoposide—lung cancer	9.1e-05	0.000727	CcSEcCtD
Haloperidol—Liver function test abnormal—Doxorubicin—lung cancer	9.09e-05	0.000726	CcSEcCtD
Haloperidol—Dyspnoea—Cisplatin—lung cancer	9.08e-05	0.000725	CcSEcCtD
Haloperidol—Skin disorder—Etoposide—lung cancer	9.06e-05	0.000724	CcSEcCtD
Haloperidol—Erectile dysfunction—Methotrexate—lung cancer	9.05e-05	0.000723	CcSEcCtD
Haloperidol—Hyperhidrosis—Etoposide—lung cancer	9.02e-05	0.00072	CcSEcCtD
Haloperidol—Feeling abnormal—Gemcitabine—lung cancer	9e-05	0.000719	CcSEcCtD
Haloperidol—Dizziness—Vinorelbine—lung cancer	8.99e-05	0.000718	CcSEcCtD
Haloperidol—Orthostatic hypotension—Doxorubicin—lung cancer	8.99e-05	0.000718	CcSEcCtD
Haloperidol—Nervous system disorder—Paclitaxel—lung cancer	8.97e-05	0.000716	CcSEcCtD
Haloperidol—Photosensitivity reaction—Methotrexate—lung cancer	8.97e-05	0.000716	CcSEcCtD
Haloperidol—Thrombocytopenia—Paclitaxel—lung cancer	8.95e-05	0.000715	CcSEcCtD
Haloperidol—Tachycardia—Paclitaxel—lung cancer	8.92e-05	0.000713	CcSEcCtD
Haloperidol—Breast disorder—Doxorubicin—lung cancer	8.89e-05	0.00071	CcSEcCtD
Haloperidol—Anorexia—Etoposide—lung cancer	8.89e-05	0.00071	CcSEcCtD
Haloperidol—Skin disorder—Paclitaxel—lung cancer	8.88e-05	0.000709	CcSEcCtD
Haloperidol—Body temperature increased—Irinotecan—lung cancer	8.86e-05	0.000708	CcSEcCtD
Haloperidol—Decreased appetite—Cisplatin—lung cancer	8.85e-05	0.000707	CcSEcCtD
Haloperidol—Hyperhidrosis—Paclitaxel—lung cancer	8.84e-05	0.000706	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Cisplatin—lung cancer	8.79e-05	0.000702	CcSEcCtD
Haloperidol—Anaemia—Docetaxel—lung cancer	8.78e-05	0.000701	CcSEcCtD
Haloperidol—Drowsiness—Methotrexate—lung cancer	8.76e-05	0.0007	CcSEcCtD
Haloperidol—Depression—Methotrexate—lung cancer	8.73e-05	0.000698	CcSEcCtD
Haloperidol—Anorexia—Paclitaxel—lung cancer	8.72e-05	0.000696	CcSEcCtD
Haloperidol—Hypotension—Etoposide—lung cancer	8.71e-05	0.000696	CcSEcCtD
Haloperidol—Vomiting—Vinorelbine—lung cancer	8.64e-05	0.00069	CcSEcCtD
Haloperidol—Body temperature increased—Gemcitabine—lung cancer	8.63e-05	0.00069	CcSEcCtD
Haloperidol—Rash—Vinorelbine—lung cancer	8.57e-05	0.000685	CcSEcCtD
Haloperidol—Dermatitis—Vinorelbine—lung cancer	8.56e-05	0.000684	CcSEcCtD
Haloperidol—Hypotension—Paclitaxel—lung cancer	8.54e-05	0.000682	CcSEcCtD
Haloperidol—Headache—Vinorelbine—lung cancer	8.52e-05	0.00068	CcSEcCtD
Haloperidol—Dysphagia—Doxorubicin—lung cancer	8.51e-05	0.000679	CcSEcCtD
Haloperidol—Leukopenia—Docetaxel—lung cancer	8.5e-05	0.000679	CcSEcCtD
Haloperidol—Feeling abnormal—Cisplatin—lung cancer	8.39e-05	0.00067	CcSEcCtD
Haloperidol—Dyspnoea—Etoposide—lung cancer	8.31e-05	0.000664	CcSEcCtD
Haloperidol—Somnolence—Etoposide—lung cancer	8.29e-05	0.000662	CcSEcCtD
Haloperidol—Hepatobiliary disease—Methotrexate—lung cancer	8.28e-05	0.000662	CcSEcCtD
Haloperidol—Insomnia—Paclitaxel—lung cancer	8.27e-05	0.000661	CcSEcCtD
Haloperidol—Hypersensitivity—Irinotecan—lung cancer	8.26e-05	0.00066	CcSEcCtD
Haloperidol—Convulsion—Docetaxel—lung cancer	8.23e-05	0.000657	CcSEcCtD
Haloperidol—Hypertension—Docetaxel—lung cancer	8.2e-05	0.000655	CcSEcCtD
Haloperidol—Agranulocytosis—Methotrexate—lung cancer	8.17e-05	0.000653	CcSEcCtD
Haloperidol—Dyspnoea—Paclitaxel—lung cancer	8.15e-05	0.000651	CcSEcCtD
Haloperidol—Somnolence—Paclitaxel—lung cancer	8.13e-05	0.000649	CcSEcCtD
Haloperidol—Decreased appetite—Etoposide—lung cancer	8.11e-05	0.000648	CcSEcCtD
Haloperidol—Pancytopenia—Doxorubicin—lung cancer	8.08e-05	0.000645	CcSEcCtD
Haloperidol—Nausea—Vinorelbine—lung cancer	8.07e-05	0.000645	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Etoposide—lung cancer	8.05e-05	0.000643	CcSEcCtD
Haloperidol—Dyspepsia—Paclitaxel—lung cancer	8.05e-05	0.000643	CcSEcCtD
Haloperidol—Body temperature increased—Cisplatin—lung cancer	8.05e-05	0.000643	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	8.03e-05	0.000641	CcSEcCtD
Haloperidol—Constipation—Etoposide—lung cancer	7.97e-05	0.000637	CcSEcCtD
Haloperidol—Neutropenia—Doxorubicin—lung cancer	7.95e-05	0.000635	CcSEcCtD
Haloperidol—Decreased appetite—Paclitaxel—lung cancer	7.95e-05	0.000635	CcSEcCtD
Haloperidol—Dry mouth—Docetaxel—lung cancer	7.91e-05	0.000632	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Paclitaxel—lung cancer	7.89e-05	0.000631	CcSEcCtD
Haloperidol—Hepatitis—Methotrexate—lung cancer	7.86e-05	0.000628	CcSEcCtD
Haloperidol—Constipation—Paclitaxel—lung cancer	7.82e-05	0.000625	CcSEcCtD
Haloperidol—Confusional state—Docetaxel—lung cancer	7.81e-05	0.000624	CcSEcCtD
Haloperidol—Urinary tract disorder—Methotrexate—lung cancer	7.76e-05	0.00062	CcSEcCtD
Haloperidol—Photosensitivity reaction—Doxorubicin—lung cancer	7.76e-05	0.00062	CcSEcCtD
Haloperidol—Oedema—Docetaxel—lung cancer	7.75e-05	0.000619	CcSEcCtD
Haloperidol—Anaphylactic shock—Docetaxel—lung cancer	7.75e-05	0.000619	CcSEcCtD
Haloperidol—Weight increased—Doxorubicin—lung cancer	7.74e-05	0.000618	CcSEcCtD
Haloperidol—Pruritus—Gemcitabine—lung cancer	7.73e-05	0.000617	CcSEcCtD
Haloperidol—Urethral disorder—Methotrexate—lung cancer	7.71e-05	0.000616	CcSEcCtD
Haloperidol—Weight decreased—Doxorubicin—lung cancer	7.7e-05	0.000615	CcSEcCtD
Haloperidol—Feeling abnormal—Etoposide—lung cancer	7.68e-05	0.000614	CcSEcCtD
Haloperidol—Hyperglycaemia—Doxorubicin—lung cancer	7.67e-05	0.000613	CcSEcCtD
Haloperidol—Diarrhoea—Irinotecan—lung cancer	7.67e-05	0.000613	CcSEcCtD
Haloperidol—ABCB1—lymph node—lung cancer	7.66e-05	0.00247	CbGeAlD
Haloperidol—Nervous system disorder—Docetaxel—lung cancer	7.6e-05	0.000607	CcSEcCtD
Haloperidol—Thrombocytopenia—Docetaxel—lung cancer	7.59e-05	0.000606	CcSEcCtD
Haloperidol—Drowsiness—Doxorubicin—lung cancer	7.58e-05	0.000606	CcSEcCtD
Haloperidol—Visual impairment—Methotrexate—lung cancer	7.58e-05	0.000605	CcSEcCtD
Haloperidol—Tachycardia—Docetaxel—lung cancer	7.56e-05	0.000604	CcSEcCtD
Haloperidol—Feeling abnormal—Paclitaxel—lung cancer	7.54e-05	0.000602	CcSEcCtD
Haloperidol—Loperamide—ABCB1—lung cancer	7.53e-05	0.106	CrCbGaD
Haloperidol—Skin disorder—Docetaxel—lung cancer	7.53e-05	0.000601	CcSEcCtD
Haloperidol—Hypersensitivity—Cisplatin—lung cancer	7.5e-05	0.000599	CcSEcCtD
Haloperidol—Diarrhoea—Gemcitabine—lung cancer	7.47e-05	0.000597	CcSEcCtD
Haloperidol—Dizziness—Irinotecan—lung cancer	7.41e-05	0.000592	CcSEcCtD
Haloperidol—Urticaria—Etoposide—lung cancer	7.41e-05	0.000592	CcSEcCtD
Haloperidol—Jaundice—Doxorubicin—lung cancer	7.39e-05	0.00059	CcSEcCtD
Haloperidol—Anorexia—Docetaxel—lung cancer	7.39e-05	0.00059	CcSEcCtD
Haloperidol—Body temperature increased—Etoposide—lung cancer	7.37e-05	0.000589	CcSEcCtD
Haloperidol—Eye disorder—Methotrexate—lung cancer	7.35e-05	0.000587	CcSEcCtD
Haloperidol—Cardiac disorder—Methotrexate—lung cancer	7.3e-05	0.000583	CcSEcCtD
Haloperidol—Urticaria—Paclitaxel—lung cancer	7.26e-05	0.00058	CcSEcCtD
Haloperidol—Hypotension—Docetaxel—lung cancer	7.24e-05	0.000578	CcSEcCtD
Haloperidol—Body temperature increased—Paclitaxel—lung cancer	7.23e-05	0.000577	CcSEcCtD
Haloperidol—Hepatobiliary disease—Doxorubicin—lung cancer	7.17e-05	0.000573	CcSEcCtD
Haloperidol—Angiopathy—Methotrexate—lung cancer	7.13e-05	0.00057	CcSEcCtD
Haloperidol—Vomiting—Irinotecan—lung cancer	7.13e-05	0.000569	CcSEcCtD
Haloperidol—Immune system disorder—Methotrexate—lung cancer	7.1e-05	0.000567	CcSEcCtD
Haloperidol—Mediastinal disorder—Methotrexate—lung cancer	7.09e-05	0.000566	CcSEcCtD
Haloperidol—Agranulocytosis—Doxorubicin—lung cancer	7.08e-05	0.000565	CcSEcCtD
Haloperidol—Rash—Irinotecan—lung cancer	7.07e-05	0.000565	CcSEcCtD
Haloperidol—Dermatitis—Irinotecan—lung cancer	7.06e-05	0.000564	CcSEcCtD
Haloperidol—Headache—Irinotecan—lung cancer	7.02e-05	0.000561	CcSEcCtD
Haloperidol—Insomnia—Docetaxel—lung cancer	7.01e-05	0.00056	CcSEcCtD
Haloperidol—Diarrhoea—Cisplatin—lung cancer	6.96e-05	0.000556	CcSEcCtD
Haloperidol—Alopecia—Methotrexate—lung cancer	6.95e-05	0.000555	CcSEcCtD
Haloperidol—Vomiting—Gemcitabine—lung cancer	6.94e-05	0.000555	CcSEcCtD
Haloperidol—Dyspnoea—Docetaxel—lung cancer	6.91e-05	0.000552	CcSEcCtD
Haloperidol—Somnolence—Docetaxel—lung cancer	6.89e-05	0.00055	CcSEcCtD
Haloperidol—Mental disorder—Methotrexate—lung cancer	6.89e-05	0.00055	CcSEcCtD
Haloperidol—Rash—Gemcitabine—lung cancer	6.89e-05	0.00055	CcSEcCtD
Haloperidol—Dermatitis—Gemcitabine—lung cancer	6.88e-05	0.00055	CcSEcCtD
Haloperidol—Hypersensitivity—Etoposide—lung cancer	6.87e-05	0.000549	CcSEcCtD
Haloperidol—Malnutrition—Methotrexate—lung cancer	6.84e-05	0.000547	CcSEcCtD
Haloperidol—Headache—Gemcitabine—lung cancer	6.84e-05	0.000547	CcSEcCtD
Haloperidol—Dyspepsia—Docetaxel—lung cancer	6.82e-05	0.000545	CcSEcCtD
Haloperidol—Hepatitis—Doxorubicin—lung cancer	6.81e-05	0.000544	CcSEcCtD
Haloperidol—Decreased appetite—Docetaxel—lung cancer	6.74e-05	0.000538	CcSEcCtD
Haloperidol—Hypersensitivity—Paclitaxel—lung cancer	6.74e-05	0.000538	CcSEcCtD
Haloperidol—Urinary tract disorder—Doxorubicin—lung cancer	6.72e-05	0.000537	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Docetaxel—lung cancer	6.69e-05	0.000534	CcSEcCtD
Haloperidol—Connective tissue disorder—Doxorubicin—lung cancer	6.69e-05	0.000534	CcSEcCtD
Haloperidol—Urethral disorder—Doxorubicin—lung cancer	6.67e-05	0.000533	CcSEcCtD
Haloperidol—Nausea—Irinotecan—lung cancer	6.66e-05	0.000532	CcSEcCtD
Haloperidol—Constipation—Docetaxel—lung cancer	6.63e-05	0.000529	CcSEcCtD
Haloperidol—Pruritus—Etoposide—lung cancer	6.6e-05	0.000527	CcSEcCtD
Haloperidol—Visual impairment—Doxorubicin—lung cancer	6.56e-05	0.000524	CcSEcCtD
Haloperidol—Nausea—Gemcitabine—lung cancer	6.49e-05	0.000518	CcSEcCtD
Haloperidol—Vomiting—Cisplatin—lung cancer	6.47e-05	0.000517	CcSEcCtD
Haloperidol—Pruritus—Paclitaxel—lung cancer	6.47e-05	0.000517	CcSEcCtD
Haloperidol—Vision blurred—Methotrexate—lung cancer	6.45e-05	0.000515	CcSEcCtD
Haloperidol—Rash—Cisplatin—lung cancer	6.42e-05	0.000513	CcSEcCtD
Haloperidol—Dermatitis—Cisplatin—lung cancer	6.41e-05	0.000512	CcSEcCtD
Haloperidol—Feeling abnormal—Docetaxel—lung cancer	6.39e-05	0.00051	CcSEcCtD
Haloperidol—Diarrhoea—Etoposide—lung cancer	6.38e-05	0.00051	CcSEcCtD
Haloperidol—Eye disorder—Doxorubicin—lung cancer	6.36e-05	0.000508	CcSEcCtD
Haloperidol—Anaemia—Methotrexate—lung cancer	6.33e-05	0.000505	CcSEcCtD
Haloperidol—Cardiac disorder—Doxorubicin—lung cancer	6.32e-05	0.000505	CcSEcCtD
Haloperidol—Diarrhoea—Paclitaxel—lung cancer	6.26e-05	0.0005	CcSEcCtD
Haloperidol—Angiopathy—Doxorubicin—lung cancer	6.18e-05	0.000493	CcSEcCtD
Haloperidol—Dizziness—Etoposide—lung cancer	6.17e-05	0.000493	CcSEcCtD
Haloperidol—Immune system disorder—Doxorubicin—lung cancer	6.15e-05	0.000491	CcSEcCtD
Haloperidol—Vertigo—Methotrexate—lung cancer	6.15e-05	0.000491	CcSEcCtD
Haloperidol—Mediastinal disorder—Doxorubicin—lung cancer	6.14e-05	0.00049	CcSEcCtD
Haloperidol—Body temperature increased—Docetaxel—lung cancer	6.13e-05	0.000489	CcSEcCtD
Haloperidol—Leukopenia—Methotrexate—lung cancer	6.13e-05	0.000489	CcSEcCtD
Haloperidol—Dizziness—Paclitaxel—lung cancer	6.05e-05	0.000483	CcSEcCtD
Haloperidol—Nausea—Cisplatin—lung cancer	6.05e-05	0.000483	CcSEcCtD
Haloperidol—Alopecia—Doxorubicin—lung cancer	6.02e-05	0.000481	CcSEcCtD
Haloperidol—Mental disorder—Doxorubicin—lung cancer	5.96e-05	0.000476	CcSEcCtD
Haloperidol—Convulsion—Methotrexate—lung cancer	5.93e-05	0.000474	CcSEcCtD
Haloperidol—Vomiting—Etoposide—lung cancer	5.93e-05	0.000474	CcSEcCtD
Haloperidol—Malnutrition—Doxorubicin—lung cancer	5.93e-05	0.000473	CcSEcCtD
Haloperidol—Rash—Etoposide—lung cancer	5.88e-05	0.00047	CcSEcCtD
Haloperidol—Dermatitis—Etoposide—lung cancer	5.87e-05	0.000469	CcSEcCtD
Haloperidol—Headache—Etoposide—lung cancer	5.84e-05	0.000467	CcSEcCtD
Haloperidol—Vomiting—Paclitaxel—lung cancer	5.81e-05	0.000464	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	5.79e-05	0.000462	CcSEcCtD
Haloperidol—Rash—Paclitaxel—lung cancer	5.77e-05	0.000461	CcSEcCtD
Haloperidol—Dermatitis—Paclitaxel—lung cancer	5.76e-05	0.00046	CcSEcCtD
Haloperidol—Headache—Paclitaxel—lung cancer	5.73e-05	0.000458	CcSEcCtD
Haloperidol—Hypersensitivity—Docetaxel—lung cancer	5.71e-05	0.000456	CcSEcCtD
Haloperidol—Muscle spasms—Doxorubicin—lung cancer	5.7e-05	0.000455	CcSEcCtD
Haloperidol—Confusional state—Methotrexate—lung cancer	5.63e-05	0.00045	CcSEcCtD
Haloperidol—Anaphylactic shock—Methotrexate—lung cancer	5.59e-05	0.000446	CcSEcCtD
Haloperidol—Vision blurred—Doxorubicin—lung cancer	5.59e-05	0.000446	CcSEcCtD
Haloperidol—Nausea—Etoposide—lung cancer	5.54e-05	0.000442	CcSEcCtD
Haloperidol—Pruritus—Docetaxel—lung cancer	5.48e-05	0.000438	CcSEcCtD
Haloperidol—Nervous system disorder—Methotrexate—lung cancer	5.48e-05	0.000438	CcSEcCtD
Haloperidol—Anaemia—Doxorubicin—lung cancer	5.48e-05	0.000438	CcSEcCtD
Haloperidol—Thrombocytopenia—Methotrexate—lung cancer	5.47e-05	0.000437	CcSEcCtD
Haloperidol—Agitation—Doxorubicin—lung cancer	5.45e-05	0.000435	CcSEcCtD
Haloperidol—Nausea—Paclitaxel—lung cancer	5.43e-05	0.000434	CcSEcCtD
Haloperidol—Skin disorder—Methotrexate—lung cancer	5.43e-05	0.000433	CcSEcCtD
Haloperidol—Hyperhidrosis—Methotrexate—lung cancer	5.4e-05	0.000431	CcSEcCtD
Haloperidol—Vertigo—Doxorubicin—lung cancer	5.32e-05	0.000425	CcSEcCtD
Haloperidol—Anorexia—Methotrexate—lung cancer	5.32e-05	0.000425	CcSEcCtD
Haloperidol—Leukopenia—Doxorubicin—lung cancer	5.31e-05	0.000424	CcSEcCtD
Haloperidol—Diarrhoea—Docetaxel—lung cancer	5.3e-05	0.000424	CcSEcCtD
Haloperidol—Hypotension—Methotrexate—lung cancer	5.22e-05	0.000417	CcSEcCtD
Haloperidol—Convulsion—Doxorubicin—lung cancer	5.13e-05	0.00041	CcSEcCtD
Haloperidol—Dizziness—Docetaxel—lung cancer	5.13e-05	0.000409	CcSEcCtD
Haloperidol—Hypertension—Doxorubicin—lung cancer	5.12e-05	0.000409	CcSEcCtD
Haloperidol—Insomnia—Methotrexate—lung cancer	5.05e-05	0.000404	CcSEcCtD
Haloperidol—Anxiety—Doxorubicin—lung cancer	5.03e-05	0.000402	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	5.01e-05	0.0004	CcSEcCtD
Haloperidol—Dyspnoea—Methotrexate—lung cancer	4.98e-05	0.000398	CcSEcCtD
Haloperidol—Somnolence—Methotrexate—lung cancer	4.97e-05	0.000397	CcSEcCtD
Haloperidol—Dry mouth—Doxorubicin—lung cancer	4.93e-05	0.000394	CcSEcCtD
Haloperidol—Vomiting—Docetaxel—lung cancer	4.93e-05	0.000394	CcSEcCtD
Haloperidol—Dyspepsia—Methotrexate—lung cancer	4.92e-05	0.000393	CcSEcCtD
Haloperidol—Rash—Docetaxel—lung cancer	4.89e-05	0.00039	CcSEcCtD
Haloperidol—Dermatitis—Docetaxel—lung cancer	4.88e-05	0.00039	CcSEcCtD
Haloperidol—Confusional state—Doxorubicin—lung cancer	4.88e-05	0.00039	CcSEcCtD
Haloperidol—Decreased appetite—Methotrexate—lung cancer	4.86e-05	0.000388	CcSEcCtD
Haloperidol—Headache—Docetaxel—lung cancer	4.86e-05	0.000388	CcSEcCtD
Haloperidol—Oedema—Doxorubicin—lung cancer	4.84e-05	0.000386	CcSEcCtD
Haloperidol—Anaphylactic shock—Doxorubicin—lung cancer	4.84e-05	0.000386	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Methotrexate—lung cancer	4.82e-05	0.000385	CcSEcCtD
Haloperidol—Nervous system disorder—Doxorubicin—lung cancer	4.74e-05	0.000379	CcSEcCtD
Haloperidol—Thrombocytopenia—Doxorubicin—lung cancer	4.74e-05	0.000378	CcSEcCtD
Haloperidol—Tachycardia—Doxorubicin—lung cancer	4.72e-05	0.000377	CcSEcCtD
Haloperidol—Skin disorder—Doxorubicin—lung cancer	4.7e-05	0.000375	CcSEcCtD
Haloperidol—Hyperhidrosis—Doxorubicin—lung cancer	4.68e-05	0.000374	CcSEcCtD
Haloperidol—Anorexia—Doxorubicin—lung cancer	4.61e-05	0.000368	CcSEcCtD
Haloperidol—Nausea—Docetaxel—lung cancer	4.6e-05	0.000368	CcSEcCtD
Haloperidol—Feeling abnormal—Methotrexate—lung cancer	4.6e-05	0.000368	CcSEcCtD
Haloperidol—Hypotension—Doxorubicin—lung cancer	4.52e-05	0.000361	CcSEcCtD
Haloperidol—Urticaria—Methotrexate—lung cancer	4.44e-05	0.000354	CcSEcCtD
Haloperidol—Body temperature increased—Methotrexate—lung cancer	4.42e-05	0.000353	CcSEcCtD
Haloperidol—Insomnia—Doxorubicin—lung cancer	4.37e-05	0.000349	CcSEcCtD
Haloperidol—Dyspnoea—Doxorubicin—lung cancer	4.31e-05	0.000344	CcSEcCtD
Haloperidol—Somnolence—Doxorubicin—lung cancer	4.3e-05	0.000343	CcSEcCtD
Haloperidol—Dyspepsia—Doxorubicin—lung cancer	4.26e-05	0.00034	CcSEcCtD
Haloperidol—Decreased appetite—Doxorubicin—lung cancer	4.2e-05	0.000336	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Doxorubicin—lung cancer	4.18e-05	0.000334	CcSEcCtD
Haloperidol—Constipation—Doxorubicin—lung cancer	4.14e-05	0.00033	CcSEcCtD
Haloperidol—Hypersensitivity—Methotrexate—lung cancer	4.12e-05	0.000329	CcSEcCtD
Haloperidol—Feeling abnormal—Doxorubicin—lung cancer	3.99e-05	0.000318	CcSEcCtD
Haloperidol—Pruritus—Methotrexate—lung cancer	3.95e-05	0.000316	CcSEcCtD
Haloperidol—Urticaria—Doxorubicin—lung cancer	3.84e-05	0.000307	CcSEcCtD
Haloperidol—Body temperature increased—Doxorubicin—lung cancer	3.82e-05	0.000305	CcSEcCtD
Haloperidol—Diarrhoea—Methotrexate—lung cancer	3.82e-05	0.000305	CcSEcCtD
Haloperidol—Dizziness—Methotrexate—lung cancer	3.69e-05	0.000295	CcSEcCtD
Haloperidol—Hypersensitivity—Doxorubicin—lung cancer	3.56e-05	0.000285	CcSEcCtD
Haloperidol—Vomiting—Methotrexate—lung cancer	3.55e-05	0.000284	CcSEcCtD
Haloperidol—Rash—Methotrexate—lung cancer	3.52e-05	0.000281	CcSEcCtD
Haloperidol—Dermatitis—Methotrexate—lung cancer	3.52e-05	0.000281	CcSEcCtD
Haloperidol—Headache—Methotrexate—lung cancer	3.5e-05	0.00028	CcSEcCtD
Haloperidol—Pruritus—Doxorubicin—lung cancer	3.42e-05	0.000273	CcSEcCtD
Haloperidol—Nausea—Methotrexate—lung cancer	3.32e-05	0.000265	CcSEcCtD
Haloperidol—Diarrhoea—Doxorubicin—lung cancer	3.31e-05	0.000264	CcSEcCtD
Haloperidol—Dizziness—Doxorubicin—lung cancer	3.2e-05	0.000255	CcSEcCtD
Haloperidol—Vomiting—Doxorubicin—lung cancer	3.08e-05	0.000246	CcSEcCtD
Haloperidol—Rash—Doxorubicin—lung cancer	3.05e-05	0.000244	CcSEcCtD
Haloperidol—Dermatitis—Doxorubicin—lung cancer	3.05e-05	0.000243	CcSEcCtD
Haloperidol—Headache—Doxorubicin—lung cancer	3.03e-05	0.000242	CcSEcCtD
Haloperidol—Nausea—Doxorubicin—lung cancer	2.87e-05	0.000229	CcSEcCtD
Haloperidol—DRD3—Signaling Pathways—SRC—lung cancer	2.1e-06	1.91e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—NQO1—lung cancer	2.09e-06	1.91e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GSTM1—lung cancer	2.08e-06	1.9e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.08e-06	1.9e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—MAPK3—lung cancer	2.08e-06	1.89e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—VEGFA—lung cancer	2.07e-06	1.89e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—EGFR—lung cancer	2.07e-06	1.89e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—PIK3CA—lung cancer	2.06e-06	1.88e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MDM2—lung cancer	2.06e-06	1.88e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—RAF1—lung cancer	2.05e-06	1.87e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—STAT3—lung cancer	2.05e-06	1.87e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—NRAS—lung cancer	2.04e-06	1.86e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—VEGFA—lung cancer	2.04e-06	1.86e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—PIK3CA—lung cancer	2.03e-06	1.85e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—ERBB2—lung cancer	2.03e-06	1.85e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—PIK3CA—lung cancer	2.03e-06	1.85e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—KRAS—lung cancer	2.03e-06	1.85e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MDM2—lung cancer	2.02e-06	1.85e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—STAT3—lung cancer	2.02e-06	1.84e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MDM2—lung cancer	2.02e-06	1.84e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—MYC—lung cancer	2.02e-06	1.84e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—RAF1—lung cancer	2.02e-06	1.84e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—NRAS—lung cancer	2.02e-06	1.84e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—RAF1—lung cancer	2.01e-06	1.84e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—PIK3CB—lung cancer	2e-06	1.83e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MTOR—lung cancer	2e-06	1.83e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—APOA1—lung cancer	2e-06	1.82e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—ERBB2—lung cancer	2e-06	1.82e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—ERBB2—lung cancer	1.99e-06	1.82e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—KRAS—lung cancer	1.99e-06	1.81e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PIK3CG—lung cancer	1.98e-06	1.81e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—APOA1—lung cancer	1.98e-06	1.81e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—EGFR—lung cancer	1.97e-06	1.8e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CYP1A1—lung cancer	1.97e-06	1.8e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MTOR—lung cancer	1.97e-06	1.8e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PIK3CB—lung cancer	1.97e-06	1.8e-05	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—PIK3CA—lung cancer	1.97e-06	1.8e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MTOR—lung cancer	1.96e-06	1.79e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PIK3CB—lung cancer	1.96e-06	1.79e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PIK3CB—lung cancer	1.96e-06	1.79e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—MAPK3—lung cancer	1.96e-06	1.79e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ERCC2—lung cancer	1.95e-06	1.78e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—KRAS—lung cancer	1.95e-06	1.78e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PTGS2—lung cancer	1.95e-06	1.77e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PIK3CG—lung cancer	1.93e-06	1.76e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—MAPK3—lung cancer	1.93e-06	1.76e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CXCL8—lung cancer	1.92e-06	1.75e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—HRAS—lung cancer	1.91e-06	1.74e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—MYC—lung cancer	1.9e-06	1.74e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.89e-06	1.73e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CXCL8—lung cancer	1.89e-06	1.73e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CXCL8—lung cancer	1.89e-06	1.72e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—STK11—lung cancer	1.89e-06	1.72e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—POMC—lung cancer	1.89e-06	1.72e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—HRAS—lung cancer	1.88e-06	1.72e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—MYC—lung cancer	1.88e-06	1.71e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—HRAS—lung cancer	1.88e-06	1.71e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—KRAS—lung cancer	1.86e-06	1.7e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—PIK3CA—lung cancer	1.86e-06	1.7e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—EGFR—lung cancer	1.86e-06	1.7e-05	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—AKT1—lung cancer	1.86e-06	1.7e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PIK3CB—lung cancer	1.85e-06	1.69e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CASP3—lung cancer	1.84e-06	1.68e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—POMC—lung cancer	1.84e-06	1.68e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IL2—lung cancer	1.84e-06	1.68e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PTGS2—lung cancer	1.84e-06	1.68e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—EGFR—lung cancer	1.84e-06	1.68e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—CREBBP—lung cancer	1.84e-06	1.68e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—IL6—lung cancer	1.83e-06	1.67e-05	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—AKT1—lung cancer	1.83e-06	1.67e-05	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—AKT1—lung cancer	1.82e-06	1.66e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—PIK3CA—lung cancer	1.82e-06	1.66e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PIK3CG—lung cancer	1.82e-06	1.66e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CASP3—lung cancer	1.81e-06	1.65e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IL2—lung cancer	1.81e-06	1.65e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CASP3—lung cancer	1.81e-06	1.65e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PIK3CG—lung cancer	1.81e-06	1.65e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IL2—lung cancer	1.8e-06	1.65e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TP53—lung cancer	1.8e-06	1.64e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—IL6—lung cancer	1.8e-06	1.64e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—IL6—lung cancer	1.8e-06	1.64e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—PIK3CA—lung cancer	1.79e-06	1.64e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—CREBBP—lung cancer	1.79e-06	1.64e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CCND1—lung cancer	1.79e-06	1.63e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—JUN—lung cancer	1.79e-06	1.63e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TP53—lung cancer	1.76e-06	1.61e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CCND1—lung cancer	1.76e-06	1.61e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—JUN—lung cancer	1.76e-06	1.61e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CCND1—lung cancer	1.76e-06	1.61e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—KRAS—lung cancer	1.76e-06	1.6e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—JUN—lung cancer	1.76e-06	1.6e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GSTP1—lung cancer	1.75e-06	1.59e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PIK3CD—lung cancer	1.74e-06	1.59e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MMP9—lung cancer	1.74e-06	1.59e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TP53—lung cancer	1.74e-06	1.58e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—KRAS—lung cancer	1.74e-06	1.58e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—POMC—lung cancer	1.73e-06	1.58e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CDKN1A—lung cancer	1.73e-06	1.58e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—PTEN—lung cancer	1.73e-06	1.58e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—HRAS—lung cancer	1.72e-06	1.57e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—POMC—lung cancer	1.72e-06	1.57e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—ALB—lung cancer	1.72e-06	1.57e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—PIK3CA—lung cancer	1.71e-06	1.56e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MMP9—lung cancer	1.71e-06	1.56e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MMP9—lung cancer	1.71e-06	1.56e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CDKN1A—lung cancer	1.71e-06	1.56e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CDKN1A—lung cancer	1.7e-06	1.55e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PTEN—lung cancer	1.7e-06	1.55e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PIK3CD—lung cancer	1.7e-06	1.55e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CAT—lung cancer	1.7e-06	1.55e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PTEN—lung cancer	1.7e-06	1.55e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PTEN—lung cancer	1.7e-06	1.55e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—APOA1—lung cancer	1.69e-06	1.54e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—CREBBP—lung cancer	1.69e-06	1.54e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—HRAS—lung cancer	1.69e-06	1.54e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—AKT1—lung cancer	1.69e-06	1.54e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—ALB—lung cancer	1.68e-06	1.53e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—CREBBP—lung cancer	1.67e-06	1.53e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—HRAS—lung cancer	1.66e-06	1.52e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—AKT1—lung cancer	1.66e-06	1.51e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TP53—lung cancer	1.66e-06	1.51e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—AKT1—lung cancer	1.66e-06	1.51e-05	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—PIK3CA—lung cancer	1.66e-06	1.51e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ABCB1—lung cancer	1.65e-06	1.51e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—IL6—lung cancer	1.65e-06	1.51e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—EP300—lung cancer	1.65e-06	1.5e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—TYMS—lung cancer	1.62e-06	1.48e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—EP300—lung cancer	1.62e-06	1.48e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—EP300—lung cancer	1.62e-06	1.48e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.62e-06	1.48e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—EP300—lung cancer	1.62e-06	1.48e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—PIK3CA—lung cancer	1.62e-06	1.47e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—IL6—lung cancer	1.62e-06	1.47e-05	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—AKT1—lung cancer	1.61e-06	1.47e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GSTM1—lung cancer	1.6e-06	1.46e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—SRC—lung cancer	1.6e-06	1.46e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PTEN—lung cancer	1.6e-06	1.46e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PIK3CD—lung cancer	1.6e-06	1.46e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—PIK3CA—lung cancer	1.59e-06	1.45e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—IL6—lung cancer	1.59e-06	1.45e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PIK3CD—lung cancer	1.59e-06	1.45e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—HRAS—lung cancer	1.59e-06	1.45e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ALB—lung cancer	1.58e-06	1.44e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—SRC—lung cancer	1.58e-06	1.44e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—SRC—lung cancer	1.57e-06	1.44e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ALB—lung cancer	1.57e-06	1.43e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TP53—lung cancer	1.56e-06	1.43e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—VEGFA—lung cancer	1.56e-06	1.43e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—STAT3—lung cancer	1.55e-06	1.41e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PIK3CG—lung cancer	1.54e-06	1.41e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NRAS—lung cancer	1.54e-06	1.41e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TP53—lung cancer	1.54e-06	1.41e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—VEGFA—lung cancer	1.54e-06	1.4e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—VEGFA—lung cancer	1.53e-06	1.4e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—EP300—lung cancer	1.53e-06	1.39e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—AKT1—lung cancer	1.52e-06	1.39e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—STAT3—lung cancer	1.52e-06	1.39e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CYP1A1—lung cancer	1.52e-06	1.39e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—STAT3—lung cancer	1.52e-06	1.39e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NRAS—lung cancer	1.52e-06	1.39e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PIK3CB—lung cancer	1.52e-06	1.38e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—IL6—lung cancer	1.52e-06	1.38e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NRAS—lung cancer	1.51e-06	1.38e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ERCC2—lung cancer	1.51e-06	1.38e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PTGS2—lung cancer	1.5e-06	1.37e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—HRAS—lung cancer	1.49e-06	1.36e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—AKT1—lung cancer	1.49e-06	1.36e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PIK3CB—lung cancer	1.48e-06	1.35e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MAPK3—lung cancer	1.48e-06	1.35e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—HRAS—lung cancer	1.47e-06	1.35e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—POMC—lung cancer	1.47e-06	1.34e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PTGS2—lung cancer	1.47e-06	1.34e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—AKT1—lung cancer	1.47e-06	1.34e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MAPK3—lung cancer	1.45e-06	1.33e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MAPK3—lung cancer	1.45e-06	1.32e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MYC—lung cancer	1.44e-06	1.31e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CREBBP—lung cancer	1.43e-06	1.31e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—IL6—lung cancer	1.43e-06	1.31e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MYC—lung cancer	1.41e-06	1.29e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—IL6—lung cancer	1.41e-06	1.29e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MYC—lung cancer	1.41e-06	1.29e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—EGFR—lung cancer	1.41e-06	1.28e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—AKT1—lung cancer	1.4e-06	1.28e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PIK3CB—lung cancer	1.4e-06	1.27e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PIK3CB—lung cancer	1.38e-06	1.26e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PTGS2—lung cancer	1.38e-06	1.26e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—EGFR—lung cancer	1.38e-06	1.26e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—EGFR—lung cancer	1.38e-06	1.26e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PTGS2—lung cancer	1.37e-06	1.25e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PIK3CD—lung cancer	1.36e-06	1.24e-05	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—AKT1—lung cancer	1.35e-06	1.23e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ALB—lung cancer	1.34e-06	1.22e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—KRAS—lung cancer	1.33e-06	1.21e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—AKT1—lung cancer	1.32e-06	1.2e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PTEN—lung cancer	1.31e-06	1.2e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—KRAS—lung cancer	1.31e-06	1.19e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—APOA1—lung cancer	1.3e-06	1.19e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—KRAS—lung cancer	1.3e-06	1.19e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—AKT1—lung cancer	1.3e-06	1.19e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PTEN—lung cancer	1.28e-06	1.17e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—EP300—lung cancer	1.25e-06	1.14e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—EP300—lung cancer	1.22e-06	1.11e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—PIK3CA—lung cancer	1.22e-06	1.11e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PTEN—lung cancer	1.21e-06	1.1e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PIK3CA—lung cancer	1.2e-06	1.1e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PIK3CA—lung cancer	1.2e-06	1.09e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PIK3CA—lung cancer	1.2e-06	1.09e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PTEN—lung cancer	1.2e-06	1.09e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PIK3CG—lung cancer	1.19e-06	1.09e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PIK3CB—lung cancer	1.18e-06	1.08e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TP53—lung cancer	1.18e-06	1.08e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PTGS2—lung cancer	1.17e-06	1.07e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TP53—lung cancer	1.16e-06	1.06e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TP53—lung cancer	1.16e-06	1.06e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—EP300—lung cancer	1.15e-06	1.05e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—EP300—lung cancer	1.14e-06	1.04e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—POMC—lung cancer	1.13e-06	1.03e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PIK3CA—lung cancer	1.13e-06	1.03e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—HRAS—lung cancer	1.13e-06	1.03e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—HRAS—lung cancer	1.11e-06	1.01e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—HRAS—lung cancer	1.11e-06	1.01e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CREBBP—lung cancer	1.1e-06	1.01e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IL6—lung cancer	1.08e-06	9.86e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IL6—lung cancer	1.06e-06	9.7e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IL6—lung cancer	1.06e-06	9.68e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PIK3CD—lung cancer	1.05e-06	9.55e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ALB—lung cancer	1.03e-06	9.43e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PTEN—lung cancer	1.02e-06	9.32e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—AKT1—lung cancer	9.97e-07	9.09e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—AKT1—lung cancer	9.81e-07	8.95e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—AKT1—lung cancer	9.78e-07	8.93e-06	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—AKT1—lung cancer	9.78e-07	8.92e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—EP300—lung cancer	9.75e-07	8.89e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PIK3CA—lung cancer	9.25e-07	8.44e-06	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—AKT1—lung cancer	9.24e-07	8.43e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PIK3CB—lung cancer	9.13e-07	8.33e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PTGS2—lung cancer	9.04e-07	8.25e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PIK3CA—lung cancer	9.03e-07	8.24e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PIK3CA—lung cancer	8.51e-07	7.77e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PIK3CA—lung cancer	8.44e-07	7.7e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PTEN—lung cancer	7.89e-07	7.2e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—AKT1—lung cancer	7.56e-07	6.9e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—EP300—lung cancer	7.52e-07	6.86e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—AKT1—lung cancer	7.38e-07	6.73e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PIK3CA—lung cancer	7.21e-07	6.58e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—AKT1—lung cancer	6.95e-07	6.34e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—AKT1—lung cancer	6.89e-07	6.29e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—AKT1—lung cancer	5.89e-07	5.37e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PIK3CA—lung cancer	5.56e-07	5.08e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—AKT1—lung cancer	4.55e-07	4.15e-06	CbGpPWpGaD
